{
    "clinical_study": {
        "@rank": "132915", 
        "arm_group": [
            {
                "arm_group_label": "Bisphosphonate implant", 
                "arm_group_type": "Active Comparator", 
                "description": "Dental implant coated with zoledronate Note: Both arms in each patient (2 implants)"
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Dental implant without coating Note: Both arms in each patient (2 implants)"
            }
        ], 
        "brief_summary": {
            "textblock": "16 patients will be included. Each patient receives 2 dental implants. One of them is coated\n      with a drug, zoledronate, to improve fixation. Fixation is measured by vibration resonance\n      frequency analysis at insertion and  2, 4, 6 and 8 weeks after insertion.The 2 implants in\n      each patient are compared. We expect to find an early improvement (higher resonance\n      frequency) in the coated implant."
        }, 
        "brief_title": "Initial Fixation of Bisphosphonate-coated Dental Implants", 
        "completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Pre-integration Failure of Dental Implant", 
        "detailed_description": {
            "textblock": "The zoledronate is linked to the titanium implant surface via a nanolayer of crosslinked\n      fibrinigen. Resonance frequency is measured with standard clinical equipment (Ostell\n      apparatus)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Need for dental implant in upper jaw. CTscan showing at least 6 mm bucco-lingual\n        thickness. Generally healthy\n\n        Exclusion Criteria:\n\n        Drugs or conditions that influence or are thought to influence bone healing, such as\n        bisphosphonates, corticosteroids, other oral pathologies, severe autoimmune diseases,\n        cancer. Osteoporosis is not cause for exclusion."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02044978", 
            "org_study_id": "Tandskruv tidsserie"
        }, 
        "intervention": {
            "arm_group_label": "Bisphosphonate implant", 
            "intervention_name": "Zoledronate-coated dental implant", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Zoledronic acid", 
                "Diphosphonates"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 22, 2014", 
        "location": [
            {
                "contact": {
                    "email": "jahan.abtahi@lio.se", 
                    "last_name": "Jahan Abtahi, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Link\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "58185"
                    }, 
                    "name": "K\u00e4kcentralen"
                }, 
                "investigator": {
                    "last_name": "Jahan Abtahi, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jahan.abtahi@lio.se", 
                    "last_name": "Jahan Abtahi, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Link\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "58227"
                    }, 
                    "name": "Tandl\u00e4karhuset"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Initial Fixation of Bisphosphonate-coated Dental Implants", 
        "overall_contact": {
            "email": "jahan.abtahi@lio.se", 
            "last_name": "Jahan Abtahi, MD, PhD"
        }, 
        "overall_contact_backup": {
            "email": "per.aspenberg@liu.se", 
            "last_name": "Per Aspenberg, MD, PhD"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: The National Board of Health and Welfare", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Each patients has a study implant and a control implant. Their change vibation frequency from insertion till measurement time point is measured and the ratio between changes for the 2 implants forms the outcome measure. Avarage values for 4 and 6 weeks will be used.", 
            "measure": "Vibration frequency ratio", 
            "safety_issue": "No", 
            "time_frame": "4 and 6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02044978"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Linkoeping", 
            "investigator_full_name": "Per Aspenberg", 
            "investigator_title": "professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Radiographic loss of bone at the margin of the implant, measured as difference in mm from the superficial bone contour between insertion and 8 weeks.", 
                "measure": "Marginal resorption", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Each patients has a study implant and a control implant. Their change vibation frequency from insertion till measurement time point is measured and the ratio between changes for the 2 implants forms the outcome measure. Avarage values for all weeks will be used.", 
                "measure": "Vibration: area under the curve", 
                "safety_issue": "No", 
                "time_frame": "2-8 weeks"
            }
        ], 
        "source": "University Hospital, Linkoeping", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Per Aspenberg", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}